CardioGenics

CardioGenics, founded in 1997 in Toronto, Ontario, is a biotechnology company dedicated to developing products for the in vitro diagnostics market to address unmet needs. At the core of the CardioGenics platform is the key technology that enhances testing sensitivity for POC products. Utilizing its core technology, CardioGenics has developed a compact POC analyzer that employs the most sensitive detection technology – chemiluminescence.